Orthofix Medical is a medical devices business based in the US. Orthofix Medical shares (OFIX) are listed on the NASDAQ and all prices are listed in US Dollars. Orthofix Medical employs 1,634 staff and has a trailing 12-month revenue of around $771.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $16.60 |
|---|---|
| 52-week range | $9.58 - $21.15 |
| 50-day moving average | $15.58 |
| 200-day moving average | $13.94 |
| Wall St. target price | $21.73 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $16.6 from 2024-09-04
| 1 week (2024-08-29) | -4.43% |
|---|---|
| 1 month (2024-08-05) | 13.78% |
| 3 months (2024-06-05) | 18.66% |
| 6 months (2024-03-05) | 27.69% |
| 1 year (2023-09-05) | -17.66% |
|---|---|
| 2 years (2022-09-02) | -15.00% |
| 3 years (2021-09-03) | 42.69 |
| 5 years (2019-09-05) | 50.61 |
Valuing Orthofix Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Orthofix Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Orthofix Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3269. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Orthofix Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Orthofix Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $26 million.
The EBITDA is a measure of a Orthofix Medical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $771.6 million |
|---|---|
| Gross profit TTM | $337.2 million |
| Return on assets TTM | -2.6% |
| Return on equity TTM | -20.32% |
| Profit margin | -15.62% |
| Book value | $14.35 |
| Market Capitalization | $665.8 million |
TTM: trailing 12 months
We're not expecting Orthofix Medical to pay a dividend over the next 12 months.
Over the last 12 months, Orthofix Medical's shares have ranged in value from as little as $9.575 up to $21.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Orthofix Medical's is 1.053. This would suggest that Orthofix Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
A deep dive into the highlights and limitations of Frec.
Compare pros, cons, research tools and reviews for these two trading platforms.
What you need to know about investing in the leading indicator for the overall US stock market.
An online REIT with low fees, consistent dividends and a stable portfolio, but a brief track record.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.